Evan J. Worden
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 8
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 4
- Cancer-related gene regulation 4
- Glycosylation and Glycoproteins Research 1
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease 3
-
- Peptidase Inhibition and Analysis 3
-
- Genetics and Neurodevelopmental Disorders 3
- Co-authors
- Andreas MartinCynthia WolbergerN. HoffmannEric EstrinKen C. DongXiangbin ZhangMark A. HerzikGabriel C. Lander
- Partner nations
- United StatesRussiaSpain
In The Last Decade
Evan J. Worden
12 papers receiving 756 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 731
- Cell Biology 166
- Structural Biology 12
- Oncology 133
- Epidemiology 146
Countries citing papers authored by Evan J. Worden
This map shows the geographic impact of Evan J. Worden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan J. Worden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan J. Worden more than expected).
Fields of papers citing papers by Evan J. Worden
This network shows the impact of papers produced by Evan J. Worden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan J. Worden. The network helps show where Evan J. Worden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evan J. Worden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2022 | 20 | |
| 4 | 2022 | 2 | |
| 5 | 2020 | 71 | |
| 6 | 2019 | 38 | |
| 7 | 2019 | 174 | |
| 8 | 2017 | 73 | |
| 9 | 2016 | 77 | |
| 10 | 2014 | 1 | |
| 11 | 2014 | 125 | |
| 12 | 2013 | 114 | |
| 13 | 2009 | 57 |
About Evan J. Worden
Evan J. Worden is a scholar working on Molecular Biology, Cell Biology and Genetics, having authored 13 papers that have together received 761 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (4 papers), Cancer-related gene regulation (4 papers), Peptidase Inhibition and Analysis (3 papers), Genetics and Neurodevelopmental Disorders (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Molecular Biology (731 citations), Cell Biology (166 citations) and Structural Biology (12 citations). Evan J. Worden has collaborated with scholars based in United States, Russia and Spain. Frequent co-authors include Andreas Martin, Cynthia Wolberger, N. Hoffmann, Eric Estrin, Ken C. Dong, Xiangbin Zhang, Mark A. Herzik, Gabriel C. Lander, Corey M. Dambacher and Bryan A. Krantz. Their work appears in journals such as Nature Structural & Molecular Biology, Molecular Cell, eLife, Proceedings of the National Academy of Sciences and Current Opinion in Structural Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.